Skip to Content

Etomidate Injection

Last Updated: May 15, 2020
Status: Current

Products Affected - Description
    • Amidate injection, Pfizer, 2 mg/mL, 20 mL LifeShield syringe, 10 count, NDC 00409-8060-29
    • Etomidate injection, Athenex, 2 mg/mL, 10 mL vial, 10 count, NDC 70860-0652-10
    • Etomidate injection, AuroMedics, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0221-10
    • Etomidate injection, AuroMedics, 2 mg/mL, 20 mL vial, 10 count, NDC 55150-0222-20
    • Etomidate injection, Hikma, 2 mg/mL, 10 mL vial, 10 count, NDC 00143-9506-10
    • Etomidate injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9507-10
    • Etomidate injection, Zydus, 2 mg/mL, 10 mL vial, 10 count, NDC 68382-0545-07 - discontinued
    • Etomidate injection, Zydus, 2 mg/mL, 20 mL vial, 10 count, NDC 68382-0545-08 - discontinued
Reason for the Shortage
    • American Regent is not currently marketing etomidate.
    • Athenex did not provide a reason for the current shortage.
    • AuroMedics did not provide a reason for the current shortage.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional has etomidate available.
    • Par Sterile Products discontinued etomidate in early 2015.
    • Pfizer has Amidate on shortage due to manufacturing delays. Pfizer discontinued etomidate ampules in October 2016.
    • Sagent is no longer marketing etomidate.
    • Zydus did not provide a reason for the shortage.
Available Products
    • Amidate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-6695-01
    • Amidate injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-6695-02
    • Etomidate injection, Athenex, 2 mg/mL, 20 mL vial, 10 count, NDC 70860-0652-20
    • Etomidate solution for injection, Fosun Pharma, 2 mg/mL, 10 mL vial, 10 count, NDC 72266-0146-10
    • Etomidate solution for injection, Fosun Pharma, 2 mg/mL, 20 mL vial, 10 count, NDC 72266-0147-10
    • Etomidate injection, Mylan Institutional, 2 mg/mL, 10 mL vial, 10 count, NDC 67457-0902-10
    • Etomidate injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 10 count, NDC 67457-0903-20

Estimated Resupply Dates

    • Athenex has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
    • AuroMedics has etomidate 2 mg/mL 10 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Hikma has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-June to early-July 2020 for the 10 mL vials and late-July 2020 for the 20 mL vials.
    • Pfizer has Amidate 2 mg/mL 20 mL LifeShield syringes on back order and the company estimates a release date of February 2021.

Safety

    • Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Updated

Updated May 15, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 6, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide